Company Profile

Kentucky Pharmaceuticals Inc (AKA: BioTech~KYPha)
Profile last edited on: 11/20/13      CAGE: 5TRJ3      UEI:

Business Identifier: detecting autoimmune and inflammatory disorders
Year Founded
2009
First Award
2010
Latest Award
2011
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

201 East Jefferson Street
Louisville, KY 40202
   (502) 819-6634
   paul@ky-pha.com
   www.ky-pha.com
Location: Single
Congr. District: 03
County: Jefferson

Public Profile

Kypha’s CompAct Test will aid in quickly detecting autoimmune and inflammatory disorders using only a single drop of blood, allowing medical professionals to gauge the seriousness of an injury or infection and monitor a patient’s recovery in real-time. Additionally, the compact size of the testing device makes it ideal for on-site treatment. Kypha hopes to bring the technology to the market following FDA approval sometime next ye

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2011 1 NIH $273,487
Project Title: Nanocomposite Imaging System For The Eye
2010 1 NIH $199,998
Project Title: Development Lateral Flow Assay

Key People / Management

  Paul K Olson -- President

  Chad Stiening